How I Diagnose Anaplastic Large Cell Lymphoma.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 33686426.
- Also identified by DOI 10.1093/ajcp/aqab012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This review describes our approach to the diagnosis of all 4 anaplastic large cell lymphoma (ALCL) entities. ALCLs are a group of CD30-positive mature T-cell lymphomas with similar morphologic and phenotypic characteristics but variable clinical and genetic features. They include systemic ALK-positive ALCL, systemic ALK-negative ALCL, primary cutaneous ALCL, and the recently described provisional entity breast implant-associated ALCL. In cases with classic features, the diagnosis of ALCL is often straightforward. However, variant histology, the importance of clinical history, and multiple antigenic aberrancies all present challenges to accurate diagnosis and subclassification. A systematic approach to the diagnosis of ALCL and awareness of potential mimics are critical to avoid misdiagnosis. It is also crucial to correctly identify localized forms of ALCL to avoid classification as systemic ALCL and subsequent overtreatment.
Medical subject headings
- Lymphoma, Large-Cell, Anaplastic